Literature DB >> 21998427

Do hospital microbiology laboratories still need to distinguish Candida albicans from Candida dubliniensis?

Shawn R Lockhart.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21998427      PMCID： PMC3232939          DOI： 10.1128/JCM.05923-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  10 in total

1.  Utility of a Luminex-based assay for multiplexed, rapid species identification of Candida isolates from an ongoing candidemia surveillance.

Authors:  Eszter Deak; Kizee A Etienne; Shawn R Lockhart; Lalitha Gade; Tom Chiller; S Arunmozhi Balajee
Journal:  Can J Microbiol       Date:  2010-04       Impact factor: 2.419

Review 2.  Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods.

Authors:  M A Pfaller; D Andes; D J Diekema; A Espinel-Ingroff; D Sheehan
Journal:  Drug Resist Updat       Date:  2010-11-02       Impact factor: 18.500

3.  Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro.

Authors:  G P Moran; D J Sullivan; M C Henman; C E McCreary; B J Harrington; D B Shanley; D C Coleman
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

4.  National surveillance of fungemia in Denmark (2004 to 2009).

Authors:  Maiken Cavling Arendrup; Brita Bruun; Jens Jørgen Christensen; Kurt Fuursted; Helle Krogh Johansen; Poul Kjaeldgaard; Jenny Dahl Knudsen; Lise Kristensen; Jens Møller; Lene Nielsen; Flemming Schønning Rosenvinge; Bent Røder; Henrik Carl Schønheyder; Marianne K Thomsen; Kjeld Truberg
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

5.  Azole susceptibility and resistance in Candida dubliniensis.

Authors:  E Pinjon; G P Moran; D C Coleman; D J Sullivan
Journal:  Biochem Soc Trans       Date:  2005-11       Impact factor: 5.407

Review 6.  Phenotypic methods and commercial systems for the discrimination between C. albicans and C. dubliniensis.

Authors:  N H Campanha; K H Neppelenbroek; D M P Spolidorio; L C Spolidorio; A C Pavarina
Journal:  Oral Dis       Date:  2005-11       Impact factor: 3.511

7.  Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.

Authors:  M A Pfaller; D J Diekema; D L Gibbs; V A Newell; D Ellis; V Tullio; A Rodloff; W Fu; T A Ling
Journal:  J Clin Microbiol       Date:  2010-02-17       Impact factor: 5.948

8.  Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.

Authors:  Marcos Martinez; José L López-Ribot; William R Kirkpatrick; Brent J Coco; Stefano P Bachmann; Thomas F Patterson
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

9.  Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals.

Authors:  D J Sullivan; T J Westerneng; K A Haynes; D E Bennett; D C Coleman
Journal:  Microbiology       Date:  1995-07       Impact factor: 2.777

Review 10.  Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans.

Authors:  Derek J Sullivan; Gary P Moran; Emmanuelle Pinjon; Asmaa Al-Mosaid; Cheryl Stokes; Claire Vaughan; David C Coleman
Journal:  FEMS Yeast Res       Date:  2004-01       Impact factor: 2.796
  10 in total
  2 in total

1.  Recent Taxonomic Developments with Candida and Other Opportunistic Yeasts.

Authors:  Mary E Brandt; Shawn R Lockhart
Journal:  Curr Fungal Infect Rep       Date:  2012-09

2.  Candida dubliniensis encrustation of an obstructing upper renal tract calculus.

Authors:  Dermot O'Kane; Anthony Kiosoglous; Kay Jones
Journal:  BMJ Case Rep       Date:  2013-08-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.